N/A N=144 Randomized Treatment

Monthly Itraconazole Versus Classic Homeopathy for Treatment of Recurrent Vulvovaginal Candidiasis (RVVC)

Vulvovaginal Candidiasis

Bottom Line

View on ClinicalTrials.gov: NCT00895453 ↗

Enrolled (actual)

144

Serious AEs

0.0%

Results posted

May 2009

Primary outcome: Primary: Candida Culture Free After Maintenance Therapy — 18; 19; 9 participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: itraconazole (Drug); lactobacillus gasseri (Drug); classic homeopathy (carcinosin M, nux vomica, pulsatilla M, ferrum metallicum, sepia M, etc. as prescribed) (Drug)
Age: Adult · 18+ yrs
Sex: Female
Sponsor: Medical University of Vienna
Primary completion: Feb 2006

Outcome Measures

Outcome	Result	p-value
PRIMARY Candida Culture Free After Maintenance Therapy	18; 19; 9	—

Summary

A prospective study to evaluate the efficacy of classic homeopathic therapy compared to maintenance itraconazole therapy with and without additional exogenous lactobacillus for treatment of recurrent Candida vaginitis.

Eligibility Criteria

Inclusion Criteria

Patients over 18 years, premenopausal
Negative pregnancy test
Signed informed consent
At least 4 Episodes of Candidiasis within the last year
Candida detectable by culture
Negative Hepatitis- and HIV-Serology
No Allergy to Itraconazole

Exclusion Criteria

Under 18 years

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00895453). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.